Clinical Trial Detail

NCT ID NCT01574729
Title Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Shenzhen SiBiono GeneTech Co.,Ltd
Indications

lung non-small cell carcinoma

Therapies

rAD-p53

Age Groups: adult

No variant requirements are available.